Waiting, hoping for a lifeline Nov 3, 2008
For Michele Makinney, a 48-year-old Kane'ohe woman with non-Hodgkin's lymphoma, a bone marrow transplant from an unrelated donor scares her so much that she really doesn't want one. "It is a dilemma I am facing right now," she said. (Honolulu Advertiser)
Allergies could ward off cancers Nov 2, 2008
But these allergies were found to be less effective against cancers of more isolated tissues such as the breast and prostate, myeloma, non-Hodgkins lymphoma and myelocytic leukemia. The relationship between asthma and lung cancer bucked the trend. (The Canberra Times)
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma Nov 1, 2008
Oct. 31 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA(R) (bendamustine hydrochloride) for Injection for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen ... Indolent NHL, a subset of non-Hodgkin's lymphoma, is a slow growing but serious cancer of the lymphatic... (PR Newswire)
Commerce reports drop in spending, income Nov 1, 2008
Cephalon Inc. received federal approval to sell its chemotherapy drug Treanda for treatment of patients with a type of non-Hodgkin's lymphoma ... The latest approval applies to Treanda for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma that has progressed despite treatment with Rituxan or a regimen containing Rituxan. (San Diego Union-Tribune -- Business)
Allergies May Protect Against Certain Types Of Cancer Oct 31, 2008
Such inverse associations were found to be far less likely for cancers of more isolated tissues like the breast, meningeal brain cells and prostate, as well as for myeloma, non-Hodgkins lymphoma and myelocytic leukemia. The relationship between asthma and lung cancer, however, is a special case. (Science Daily)
Genmab Announces Results for the First Nine Months of 2008 Oct 30, 2008
- We completed recruitment in a second pivotal ofatumumab study in refractory non-Hodgkin's Lymphoma (NHL) patients and in two Phase II studies. Data from all three are expected in 2009. (PR Newswire)
Clean bill of health: Kevin Feeley survived cancer, but the bills are piling up Oct 30, 2008
That PET scan was the test which revealed his body is clear of cancer after a long battle with non-Hodgkin's lymphoma over the last year. According to Amanda, Kevin began suffering from symptoms during the summer of 2007. (Ames Daily Tribune, IA)
Adventist Health chairman dies Oct 29, 2008
Jere D. Patzer, chairman of s board of directors and president of the North Pacific Union Conference of Seventh-Day Adventists, died Sunday after a long battle with non-Hodgkins lymphoma. He was 61. (Sacramento Business Journal, CA)
Race for Hope helps cancer patients Oct 28, 2008
Martin, honorary race ambassador for the Cancer Center, was diagnosed with non-Hodgkins lymphoma four years ago, said Jean Gill, race director. His message is clear, "If you think something's not right, get it checked out as soon as possible. I was fortunate it was caught when it was. I'd say I felt symptoms for less than two months before I got the diagnosis.". (Sioux City Journal, IO)
2,000 participate in annual Road America Run/Walk Oct 27, 2008
Renzelmann, 46, was diagnosed in 1992 with non-Hodgkin's lymphoma, and the cancer returned twice. In 1998, he received a bone-marrow transplant from his older brother, Terry, only two days before the Road America race. (Yahoo News -- Auto Racing)
Robust 3.6 Percent Annual Growth in the Non-Hodgkin's Lymphoma Drug Market will be Driven by the Continued Dominance of Rituxan/MabThera Oct 21, 2008
6 Percent Annual Growth in the Non-Hodgkin's Lymphoma Drug Market will be Driven by the Continued Dominance of Rituxan/MabThera ... 6 Percent Annual Growth in the Non-Hodgkin's Lymphoma Drug Market will be Driven by the Continued Dominance of Rituxan/MabThera ... 6 percent annual growth in the non-Hodgkin's lymphoma drug market will be driven by increasing market penetration of Biogen Idec/Genentech/Chugai/Zenyaku Kogyo's Rituxan/Roche's MabThera, particularly in the chronic lymphocytic leukemia... (PR Newswire)
Roche Sales Rise on Increased Demand for Avastin (Update1) Oct 21, 2008
3 percent, while sales of MabThera, used to treat non-Hodgkin's lymphoma and rheumatoid arthritis, increased 6. 5 percent. (Bloomberg)
Cal goalie won't let cancer keep her off the field Oct 21, 2008
The tumor was non-Hodgkin's lymphoma. LaFontaine-Kussmann stayed in school and never wore the wig she bought. (San Diego Union-Tribune -- Sports)
Marathon's twin causes: cancer, female athletes Oct 21, 2008
who was diagnosed with non-Hodgkin's lymphoma in 2004. "If it wasn't for recent breakthroughs in treatment, she'd be dead right now," Driscoll said. (San Francisco Chronicle)
High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma Oct 20, 2008
Novel Outpatient Regimen Pioneered by Investigators from Tumor Institute in Milan SEATTLE, Oct. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Journal of Clinical Oncology has published the results of an innovative study that investigated high (bone marrow ablative) dose Zevalin(R) ([90Y]-ibritumomab tiuxetan) followed by autologous stem cell infusions among 30 patients (median age 62 years) with relapsed/refractory or high risk... (PR Newswire)
Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkin's Lymphoma Oct 16, 2008
Zevalin(R) First-Line Indolent (FIT) Phase III Clinical Trial results published in Journal of Clinical Oncology SEATTLE, Oct. 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Journal of Clinical Oncology has published the results of the First-line Indolent Trial (FIT) demonstrating that use of Zevalin(R)([90Y]-ibritumomab tiuxetan) in consolidation therapy after remission induction in previously untreated patients with follicular... (PR Newswire)
Genentech profit rises, sales top estimates Oct 15, 2008
U.S. sales of Rituxan for non-Hodgkin's lymphoma and rheumatoid arthritis jumped 15 percent to 655 million, exceeding analysts' expectations of 648 million ... non-Hodgkin's lymphoma. (Yahoo News -- Pharmaceutical Industry News)
UNMC On Cutting-Edge Of Lymphoma Research Oct 14, 2008
Vose specializes in treating lymphoma which is made up of many forms but is commonly known as Hodgkins or non-Hodgkins lymphoma ... Omaha attorney Jim Cavanaugh has been part of many of clinical trials after his diagnosis of non-Hodgkins lymphoma in 1999. (7 KETV Omaha)
ALCS: Young ace Lester leads Sox back into Fenway (Today) Oct 13, 2008
Although there's little precedent for a pitcher recovering from non-Hodgkins lymphoma, the Red Sox did what research they could on how to get him back to full strength. Their conclusion: take it slow. (Pittsburgh Post-Gazette, PA -- Sports)
Transplant survivors gather to celebrate life Oct 13, 2008
In 2001, Troy Ford was on death s door with non-Hodgkins lymphoma, a form of cancer. In three weeks, he s competing in an Ironman triathlon. (Atlanta Journal-Constitution -- Health)
McCain wrong to hold back biopsy details Oct 10, 2008
The history of American presidential campaigns is punctuated by examples of candidates medical problems hidden from the public the ominous physical condition of Franklin D. Roosevelt as he campaigned for a fourth term, the presence of Addison s disease in John F. Kennedy, the true extent of Paul Tsongas non-Hodgkins lymphoma that killed him two days before he would have completed his first term, had he been elected president. Now we have the case of John McCain, who has kept the curtain closed... (Atlanta Journal-Constitution -- Opinion)
Good News For Rituxan Oct 8, 2008
3 billion in 2007, is approved by the U.S. Food and Drug Administration for the treatment of rheumatoid arthritis and non-Hodgkin's lymphoma. The drug targets a type of immune cell that has a specific protein within it; this is the common factor in all of these diseases. (Forbes)
');document.writeln("Five things we learned in the ALDS");document.writeln(' Oct 8, 2008
Lester arrived in the AL three years ago as Boston's top pitching prospect, but his career was interrupted by non-Hodgkin's lymphoma toward the end of his rookie year, and his 2007 campaign was devoted largely to rehab and reestablishing himself after beating the disease over the offseason. Though he started and won the decisive Game 4 of last year's World Series, Lester didn't start in the first two rounds of the 2007 postseason, and was still finding himself this April, posting a 5. (SportsIllustrated.CNN)
Ruth Ann Espo, 71, community activist Oct 4, 2008
Mrs. Espo was diagnosed and treated for non-Hodgkins lymphoma in 1992. She survived after a stem cell transplant at New England Medical Center. (Boston Globe)
Cancer chronicles Oct 3, 2008
A 12-year cancer survivor, Reno was diagnosed with stage IV follicular non-Hodgkin's lymphoma at age 35 ... Dr. John Gallen, who lives in Poway and also shares his story in the book, turned to alternative treatments in his battle against non-Hodgkin's lymphoma. (North County Times)
Lilly is potential ImClone suitor with $6.1 billion offer Oct 3, 2008
Lilly also has a drug in late-stage testing for non-Hodgkin's lymphoma. But Gemzar will lose patent protection early next decade. (International Herald Tribune -- Business)
Friday's Light the Night to benefit cancer group Sep 24, 2008
The group estimates that 279 out of 100,000 Capital Region residents will be diagnosed with some type of blood cancer this year, including leukemia, multiple myeloma, Hodgkin's lymphoma and non-Hodgkin's lymphoma. The Light the Night walk helps fund adult and youth support groups, education programs, financial aid for needy patients and educational materials for hundreds of local patients with blood cancer. (Albany Times Union)
FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion Sep 22, 2008
The sBLA will propose a label expansion to include use of the Zevalin(R) therapeutic regimen ([90Y]-ibritumomab tiuxetan) as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma ... "Label expansion for first-line indication would make this important treatment option available to the tens of thousands of patients who may benefit." Zevalin is currently approved in the United States for the treatment of patients with relapsed or... (PR Newswire)
Buck CEO founds Prevarex to help people live longer Sep 18, 2008
Likewise, GSK has options for joint development of the Phase I cancer drug ispinesib and a Phase I/II drug to treat Hodgkin's and non-Hodgkin's lymphoma. Cytokinetics, seeded in 1998 by founder Bob Swanson and former chairman and CEO Roy Vagelos, lost $13. (San Francisco Business Times, CA)
FDA cites brain virus with Genentech, Biogen drug Sep 13, 2008
The drug is also approved for non-Hodgkin's lymphoma ... non-Hodgkin's lymphoma. (Yahoo News -- Pharmaceutical Industry News)
Galvin, Coakley to testify about trading scandal Sep 12, 2008
The drug is also approved for non-Hodgkin's lymphoma. A Genentech spokeswoman noted the drug's label already mentions risks of the infection. (Boston Globe)
UPDATE 1-Genentech revises Rituxan warning after death Sep 12, 2008
Rituxan also is approved for treating non-Hodgkin's lymphoma. (Reporting by Lisa Richwine and Deena Beasley; Editing by Leslie Gevirtz, Bernard Orr). (Reuters)
The IMF says journal editorial documents dramatic increase in survival since the 1980s Sep 12, 2008
Dr. Durie notes these achievements with myeloma are now benefiting a wide range of blood cancers as these drugs are being tested in non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other blood cancers. In the editorial he says the next step is to identify new agents with "greater efficacy or lesser toxicities" in this setting of already high response rates. (EurekAlert!)
Former NMSU Head Coach Gives Statement On Passing Of Haskins Sep 9, 2008
In 2003 he had chemotherapy for non-Hodgkin's lymphoma. Responding about his own health, Henson said, I am doing very well, and getting better all the time. (KFOXTV.com, TX)
Malignant Lymphoma and Autoimmune D... Sep 8, 2008
Several autoimmune conditions, such as Sjogren's syndrome, thyroiditis, and rheumatoid arthritis, have consistently been linked to malignant or non-Hodgkin's lymphoma. In recent years, the worldwide incidence of malignant lymphoma has increased dramatically, and the number of autoimmune diseases linked to non-Hodgkin s lymphoma (NHL) has also increased. (Suite101.com)
Brother saves Hammond cop's life (4255) Sep 5, 2008
In April 2007, Kris Howard was diagnosed with stage four non-Hodgkins lymphoma. The treatment kept him away from his job for 375 days, and hospital stays were hard to explain to his son Ricky, now 5. (Munster Times, IN)
HEALTH BLOG: Digging into the latest cancer studies Aug 28, 2008
Stanford scientists are using tobacco plants to grow antibodies against the cells that cause follicular B-cell lymphoma, a type of non-Hodgkin's lymphoma, the BBC. Women might be more likely to get tattoos, but they're also more likely to get them removed, at least according to a small in the latest issue of the Archives of Dermatology. (USA Today -- Money)
A new weapon to fight cancer - tobacco? Aug 22, 2008
The made-to-order vaccine has been tested in an early-stage clinical trial, and it showed an immune response in 70 percent of non-Hodgkin's lymphoma patients without harmful side effects. Even though it is called a vaccine, it will not prevent a person from getting non-Hodgkin's lymphoma, which is the seventh-leading cause of cancer-related deaths in the United States ... Arntzen said that non-Hodgkin's lymphoma is a relatively low-moving cancer, so it gives researchers time to grow, cultivate... (AZCentral -- Business)
Heads-up Study Of Hair Dynamics May Lead To Better Hair-care Products Aug 21, 2008
17, 2004) Yale researchers have found that lifetime users of hair coloring products have an increased risk of developing non-Hodgkin's lymphoma (NHL), a cancer that attacks the lymphatic system, part of. (June 12, 2007) Male pattern hair loss is a condition that affects as many as 50 percent of men by the age of fifty, but according to a new study, baldness may soon be a treatable. (Science Daily)
Race for Hope a celebration, remembrance Aug 20, 2008
SIOUX CITY -- Steve Martin was diagnosed with non-Hodgkins lymphoma four years ago this month. It was stage 4, the final stage of the fast, aggressive cancer. (Sioux City Journal, IO)
Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results Aug 18, 2008
-- Scheduled meeting with the U.S. Food and Drug Administration (FDA) in September to discuss the possibility of filing a sBLA for use of Zevalin as consolidation therapy after remission induction in previously untreated patients with follicular non-Hodgkin's lymphoma based on FIT trial data ... Specifically, the risks and uncertainties include statements about future sales of Zevalin, including the risk that the data from the FIT trial may not prove adequate to support an sBLA for label... (PR Newswire)
Cancer vaccine trial results fail to boost Accentia stock Aug 18, 2008
Accentia reported in July that the vaccine, in Phase III trials, improved the disease-free survival of non-Hodgkin's lymphoma patients. Local ophthalmologist-turned-entrepreneur Dr. Frank O'Donnell, chief executive of Tampa, Fla. (St. Louis Business Journal, MO)
Accentia Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice Aug 18, 2008
BiovaxID is being developed as a vaccine to treat non-Hodgkins lymphoma. There also was a decrease in SinuNase research and development expenses due to the completion of its Phase 3 clinical trial, the company said. (St. Louis Business Journal, MO)
1995 OHS baseball team makes history with outstanding season Aug 17, 2008
Just four years later in the winter of 1999, Hoffman died of a heart attack from complications from Non-Hodgkins Lymphoma. I talk about Hoffman all the time. (Ontario Argus Observer, OR)
'Bond was shaken, stirred and very angry' Aug 16, 2008
Welcome to Herald Sun. Bond was shaken, stirred and very angry. (Melbourne Herald Sun)
Antibody Drug Unleashes Tumor-Killer T Cells Aug 16, 2008
The technology is only in early human clinical trials, but if it proves effective, this new antibody a protein employed by the immune system to ferret out foreign invaders could offer way to stop non-Hodgkin's lymphomas, a type of cancer, in its tracks. More than 65,000 Americans have been diagnosed with non-Hodgkin's lymphoma thus far in 2008, , and nearly 20,000 have died from it. (Scientific American)
Cancer and immunotherapy Q and A Aug 16, 2008
This particular antibody, called blinatumomab, is expected to not only work in non-Hodgkin's lymphoma but also in aggressive leukaemia and lymphoma too ... Aside from non-Hodgkin's lymphoma, a cancer of the lymphatic system, phase one and two clinical trials of the BiTE antibodies are now under way in Europe, including on patients with lung and gastrointestinal cancer. (Telegraph.co.uk)
Patients free of cancer Aug 15, 2008
Four out of 38 patients with non-Hodgkin's lymphoma saw the disease disappear, while five others saw reductions of 50 per cent in their tumours. The drug, which could be cheaper than other similar therapies, works by activating the body's own defences to attack the cancer. (Sydney Morning Herald -- World)
Hartley inspired by fallen sibling Aug 15, 2008
In July of 2007, Dr. Strachan Hartley, a former football player at the University of British Columbia and McGill University, died of non-Hodgkin's lymphoma. He was 30. (Globe and Mail -- Sports)
Genentech coy about Roche bid Aug 14, 2008
Its rheumatoid arthritis and non-Hodgkin's lymphoma drug Rituxan posted nearly $2. 3 billion in sales, while the breast cancer treatment Herceptin had sales of $1. (NJ.com -- Times)
China's first transgenic cow born to help fight cancer Aug 12, 2008
CD20 cell-surface proteins found in mature B cells become cancerous in patients who suffer from non-Hodgkins lymphoma, which accounts for about 40 percent of all new cases of lymphoma. It is identified as the target in the treatment of lymphomas. (Xinhuanet, China)
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin’s Lymphoma Aug 7, 2008
NEJM -- Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma ... Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma ... 1 Approximately 85% of non-Hodgkin's lymphomas in adults are of B cell origin. (New England Journal of Medicine)
Biovest joins cancer research collaborative Aug 6, 2008
Biovest was cited for its current efforts to commercialize BiovaxID, a personalized biologic therapeutic cancer vaccine now completing Phase 3 clinical trials to treat non-Hodgkin's lymphoma, the company said in the release. Biovest also is the developer and manufacturer of AutovaxID, a patented technology enabling cancer vaccines to be developed much more rapidly and cost-effectively than current systems, the release said. (Tampa Bay Business Journal, FL)
Mutual Funds &Personal Finance Aug 6, 2008
Research suggests that Revlimid may be accepted as a treatment for non-Hodgkins lymphoma and for chronic lymphocytic leukemia. Celgene's pretax margin has been 9. (Investors Business Daily)
Craig W. Philips Takes Helm at CTI Aug 5, 2008
"I look forward to helping to bring value to CTI shareholders, and to improving the treatment options available to individuals suffering with cancer." In late 2007, CTI acquired the U.S. sales and marketing rights to Zevalin, a drug for treating relapsed follicular non-Hodgkin's lymphoma (NHL) ... A new chemical compound for the treatment of non-Hodgkin's lymphoma (NHL), and various other hematologic malignancies, solid tumors, and immunological disorders, pixantrone is being developed by CTI to... (PR Newswire)
Advanced Medical Isotope Corporation Delivers Initial Shipment of Short-Lived Radioisotopes to Kadlec Medical Center Aug 5, 2008
FDG is being utilized for a variety of purposes, including diagnosis and monitoring the treatment of Hodgkin's disease, non-Hodgkin's lymphoma, Alzheimer's disease, and lung cancer. About Kadlec Medical Center. (Primezone Releases)
Agent Orange Linked to Aggressive Prostate Cancer Aug 5, 2008
"While others have linked Agent Orange to cancers such as soft-tissue sarcomas, Hodgkin's disease and non-Hodgkin's lymphoma, there is limited evidence so far associating it with prostate cancer," said Karim Chamie, lead author of the study and resident physician with the UC Davis Department of Urology and the VA Northern California Health Care System. "Here we report on the largest study to date of Vietnam War veterans exposed to Agent Orange and the incidence of prostate cancer.". (Newsmax)
The final fine print Aug 4, 2008
He became ill in 2003 with non-Hodgkin's lymphoma but continued to work as a lawyer until May 2005 when his employment was terminated due to poor performance. He claimed this was a result of his illness. (Sydney Morning Herald)
Biogen Banks On Tysabri Aug 2, 2008
Sales of Rituxan, a treatment for rheumatoid arthritis and non-Hodgkin's lymphoma that it co-markets in the U.S. with Genentech (nyse: - - ), rose 13. 1% to $605 million; Biogen received $247 million from that partnership. (Forbes)
Biogen: 2 patients get brain disease Aug 1, 2008
For instance, another Biogen Idec drug, Rituxan, used to treat non-Hodgkin's lymphoma and rheumatoid arthritis, also carries a PML warning on its label. cancer drug Campath has also been linked to PML. But the concern is especially strong about Tysabri because two patients died when the drug was new and still in limited use. (Boston Globe)
Newsweek: Survive cancer, have a baby Jul 31, 2008
When 's oncologist told her she'd need a stem-cell transplant to cure her non-Hodgkin's lymphoma, Dauer's first thought wasn't about death but about life. "I asked what would happen to my fertility," she says. (MSNBC -- Health)
Pharma majors focus on speciality, niche drugs to ride global boom Jul 28, 2008
Dr Reddy's introduced its second bio-generic product rituximab, a monoclonal antibody used in the treatment of non-hodgkins lymphoma, a kind of cancer, last year. The drug contributed over Rs 15 crore in revenues in 2007-08. (India Times, India -- Intl Business)
Elizabeth Campbell; counselor fought to change adoption laws Jul 28, 2008
Mrs. Campbell, who was also a champion of overhauling adoption laws to make it easier for adoptees to gain access to their birth certificates, died from complications of leukemia and non-Hodgkin's lymphoma on July 4 at her home in Sudbury. She was 62. (Boston Globe)
Cancer Vaccine From Tobacco Plants? Jul 25, 2008
An experimental has been proven to work as a helpful cure for a fatal form of non-Hodgkin's lymphoma. Although the vaccine is not strong enough to work on its own, after further research it could become a life-saving supplement to chemotherapy. (CollegeOTR)
Tobacco Plants Can Become An Important Ally In Fight With Cancer Jul 25, 2008
According to the Evening Bulletin, researchers have discovered that the tobacco plant can help cure a specific type of non-Hodgkin's lymphoma. Monday, scientists at the Stanford University School of Medicine in California published a study in a National Academy of Science journal, explaining that tobacco plants can grow antibodies which will fight cancer. (eFluxMedia)
